NIFTY
13.90  0.12%
 11214.05
S&P BSE SENSEX
15.12  0.04%
 38040.57
Cipla Ltd.
NSE : CIPLA BSE : 500087 ISIN code : INE059A01026
on 07-Aug-2020
NSE
-2.45    -0.34%
Rs. 728.65
 
Days Low
Rs. 724.75
Days High
Rs. 739.6

Open Rs. 739
 
52 week Low
Rs. 356.75
52 week High
Rs.739.6
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.728.60
-3.1    -0.42%
on 07-Aug-2020
BSE
-3.1    -0.42%
Rs. 728.60
 
Days Low
Rs. 724.5
Days High
Rs. 739.65

Open Rs. 738
 
52 week Low
Rs. 355.3
52 week High
Rs.739.7
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.728.65
-2.45    -0.34%
 
 
Last Price (Rs.)  728.60 Value  186248567.00
Net Change (Rs.)  -3.10 Best Buy  0.00
Volume  254886 Best Sell  0.00
Prev.Close (Rs.)  731.70 Best Quantity  0
Open (Rs.)  739.00 Sell Quantity  0
High (Rs.)  739.60 52-Week High (Rs.)  739.60
Low (Rs.)  724.75 52-Week Low (Rs.)  356.75
Face Value (Rs.)  2 Market Cap.(Rs/ Mn)  587476.08
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital1612.50 1611.40 1610.20 
Share Capital1612.50 1611.40 1610.20 
Share Capital1612.50 1611.40 1610.20 
Share Capital1612.50 1611.40 1610.20 
Share Capital1612.50 1611.40 1610.20 
Currents Investments8344.30 20115.80 10397.40 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 525.80 1261570 103.90 39.29 0.76
Dr. Reddys Lab 4571.25 759890 964.81 25.86 0.55
Divis Lab 2784.25 739131 294.16 55.46 0.57
Aurobindo Pharma 906.65 531241 222.30 28.37 0.33
Torrent Pharma 2940.60 497575 320.25 53.03 1.09
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Jun 2020Mar 2020Dec 2019
Net Sales31280.2031334.4029262.00
Operating Profit9904.008782.105102.20
PBDT9761.908689.705006.70
Net Profit6103.006045.702822.20
More> 
 
Company News
8/8/2020 12:00:00 AM
Cipla submits newspaper publication
7/27/2020 12:00:00 AM
Cipla, Precision Camshafts and Jenburkt Pharmaceuticals to see some ac...
7/27/2020 12:00:00 AM
Cipla gains on getting DCGI’s nod to launch Ciplenza in India to treat...
More>
 
Ratios
   Earnings Per Share (Rs)28.75 
   Book NAV/Share(Rs)215.43 
   PAT Margin (%)17.10 
   Asset Turnover(x)0.70 
   PER(x)14.71 
   Yield(%)0.95 
   EV/Core EBITDA(x)9.38 
   M Cap / Sales2.69 
   Net Sales Growth(%)2.30 
   PAT Growth(%)22.76 
   Total Debt/Equity(x)0.00 
   Current Ratio(x)3.45 
   Quick Ratio(x)2.30 
   Total Debt/Mcap(x)0.00 
More>